Login for PhD students at UCPH      Login for others
Biobanking in the era of personalised medicine
Provider: Faculty of Health and Medical Sciences

Activity no.: 3687-21-00-00 
Enrollment deadline: 17/10/2021
Date and time15.11.2021, at: 09:00 - 19.11.2021, at: 17:00
Regular seats20
Course fee6,720.00 kr.
LecturersLasse Boding
ECTS credits3.50
Contact personAnne Vitoft    E-mail address: avt@ssi.dk
Enrolment Handling/Course OrganiserPhD administration     E-mail address: phdkursus@sund.ku.dk

Aim and content
This course is free of charge for PhD students at Danish universities (except Copenhagen Business School), and for PhD students at graduate schools in the other Nordic countries. All other participants must pay the course fee.

Anyone can apply for the course, but if you are not a PhD student at a Danish university, you will be placed on the waiting list until enrollment deadline. This also applies to PhD students from Nordic countries. After the enrollment deadline, available seats will be allocated to applicants on the waiting list.

Learning objectives
A student who has met the objectives of the course will be able to:

1. Understand the many facets of modern biobanking and the link to personalised medicine

2. Be able to apply for required ethical and data approvals

3. Undertake a solid research project based on biobank samples

4. Discuss the ELSI aspects (ethical, legal and societal implications) of biobanking

5. See the patients perspective and how biobanking research impacts on the society

The objective of this 5-day PhD course is to give insights and later deepen the student’s understanding in the multidisciplinary world of biobanking. Offered as a collaboration between Copenhagen and Lund Universities and with the collaboration of Danish National Biobank, University of Helsinki and The Spanish National Cancer Research Centre, the course aims to provide the students with a core set of tools to gain better understanding of the key role of biobanking in translational medicine.

The goal is to provide an interdisciplinary perspective on the historical, philosophical, ethical, legal, social, technical and cultural aspects related to the collection, storage, use and dissemination of human biological samples and health information. After completion of the course, the students will have a broad understanding of biobanking, as well as the challenges associated with collaboration between the different stakeholders. The course also offers a site visit to the Danish National Biobank.

PhD students with an interest in biobanking, personalised medicine and related research

Relevance to graduate programmes
The course is relevant to PhD students from the following graduate programmes at the Graduate School of Health and Medical Sciences, UCPH:

All graduate programmes


5-day intensive seminar which includes a 2-day symposium and onsite visit to the Danish National Biobank (Copenhagen). Assigned reading package, active participation in class discussions and working groups, course assignment in working group (oral presentation).

Course director
Lasse Boding, PhD, Head of Unit, Danish National Biobank, Statens Serum Institut, labo@ssi.dk

Lasse Boding, Head of Unit, Danish National Biobank, Statens Serum Institut
Eva Ortega-Paino, Research Director, Spanish National Cancer Institute
Bart Wilkowski, Head of IT, Danish National Biobank
Aaro Tupasela, Docent, University of Helsinki
Peter Nilsson, Professor, Lund University
Alexander Lind, Postdoc, Lund University
Mette Hartlev, Professor University of Copenhagen
Johan Modin, Director, Swedish Ethical Review Authority
Klaus Høyer, Professor, University of Copenhagen
Marina Pollan, Professor, Health Institute Carlos III, Madrid
Peter Garred, Professor, University of Copenhagen
Niels Tommerup, Professor, University of Copenhagen
Tune Pers, Associate Professor, University of Copenhagen
Søren Brunak, Professor, University of Copenhagen
Marco Hautalahti, CEO, Finnish Biobanks Cooperative (FINBB), Finland
Frederik Knud Nielsen, Strategic Pipeline Lead, Novartis
Marianne Pilgaard, CEO, Trial Nation
Lila Kallio, Director, Auria Biobank, Turku, Finland
Jens Habermann, Director General, BBMRI-ERIC
Sandra Liede, Lawyer, Healthtech Finland
Jakob Bjerg Larsen, Head of Clinical Trials and and Pharmaceutical Manufacturing Policy, The Danish Association of the Pharmaceutical Industry (LIF)

15 - 19 November 2021
All days 9 - 17

Course location

Please register before 17 October 2021

Seats to PhD students from other Danish universities will be allocated on a first-come, first-served basis and according to the applicable rules.
Applications from other participants will be considered after the last day of enrolment.

Note: All applicants are asked to submit invoice details in case of no-show, late cancellation or obligation to pay the course fee (typically non-PhD students). If you are a PhD student, your participation in the course must be in agreement with your principal supervisor.

Click the search button to search Courses.

Course calendar
See which courses you can attend and when

New courses
Courses are published regularly. High demand courses are announced in spring and autumn.

Learn which courses are announced on fixed dates